Related Experiment Video
Updated: Jun 6, 2026

05:46
Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
Published on: December 2, 2022
Conjunctival Melanoma: A New Clinical and Therapeutical Approach
M Rodríguez-Martín1, J Rodríguez-Martín, N Merino de Paz
1Department of Dermatology, Hospital Universitario de Canarias, University of La Laguna, La Laguna, Spain.
Case Reports in Dermatology
|November 16, 2010
Summary
This study reports a rare case of conjunctival melanoma, a serious eye cancer. It highlights novel therapeutic approaches including topical imiquimod for ocular melanoma.
Area of Science:
- Ophthalmology
- Dermatology
- Oncology
Background:
- Conjunctival melanoma is a rare ocular malignancy with a poorer prognosis than cutaneous melanoma.
- Risk factors for conjunctival melanoma mortality include advanced age and unfavorable tumor location.
Observation:
- This case involves lentigo maligna affecting the palpebral conjunctiva, bulbar conjunctiva, and caruncle.
- Dermoscopic patterns of this rare ocular melanoma were documented.
Findings:
- The study presents a rare case of conjunctival melanoma involving multiple ocular structures.
- Dermoscopy provided insights into the tumor's characteristics.
- Topical imiquimod was explored as a novel therapeutic option.
Implications:
- This case expands understanding of rare ocular melanoma presentations.
- It suggests potential new treatment avenues for conjunctival melanoma.
- Further research into topical imiquimod for ocular cancers is warranted.
Related Concept Videos
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Changes in Skin Color: Clinical Perspectives
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...

